Koers Univo Pharmaceuticals Ltd TEL AVIV STOCK EXCHANGE
Aandelen
UNVO
IL0010935588
Biotechnologie & Medisch Onderzoek
Omzet 2019 | 0,82 3,04 0,76 | Omzet 2020 | 33,68 124,39 31,11 | Marktkapitalisatie | 75,1 mln. 277 mln. 69,37 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2019 | -11 mln. -40,63 mln. -10,16 mln. | Nettowinst (verlies) 2020 | - 0 0 | EV/omzet 2019 | 35.543.010 x |
Nettoliquiditeiten 2019 | 22,82 mln. 84,28 mln. 21,08 mln. | Nettoschuld 2020 | 4,12 mln. 15,22 mln. 3,81 mln. | EV/omzet 2020 | 2.352.105 x |
K/w-verhouding 2019 * |
-
| K/w-verhouding 2020 |
-
| Werknemers | - |
Dividendrendement 2019 * |
-
| Dividendrendement 2020 |
-
| Vrij verhandelbaar | 59,28% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Golan Bitton
CEO | Chief Executive Officer | 48 | 04-04-93 |
Jonathan Eilat
IRC | Investor Relations Contact | - | - |
Noam Frakash
AUD | Comptroller/Controller/Auditor | 41 | 01-01-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chaim Hurvitz
CHM | Chairman | 63 | 15-07-19 |
Golan Bitton
CEO | Chief Executive Officer | 48 | 04-04-93 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+29,03% | 48,16 mld. | |
-0,10% | 41,73 mld. | |
+43,45% | 41,03 mld. | |
-5,26% | 28,77 mld. | |
+11,48% | 25,59 mld. | |
-22,74% | 18,96 mld. | |
+9,06% | 12,92 mld. | |
+30,01% | 12,03 mld. | |
-1,51% | 11,77 mld. |